As of 2025-04-28, the Relative Valuation of Origin Therapeutics Holdings Inc (ORIG.CN) is 0.28 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.28 CAD, the upside of Origin Therapeutics Holdings Inc based on Relative Valuation is 2.0%.
The range of the Relative Valuation is 0.28 - 0.28 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -0.5x - -0.5x | -0.5x |
| Fair Price | 0.28 - 0.28 | 0.28 |
| Upside | 2.0% - 2.0% | 2.0% |
| Date | P/E |